Skip to main content

Table 1 Body weight, body condition score and vital signs of myxomatous mitral valve degenerative dogs pre- and post-treatment in the control and treatment groups

From: Short-term melatonin supplementation decreases oxidative stress but does not affect left ventricular structure and function in myxomatous mitral valve degenerative dogs

Parameter

Control group (n = 11)

Treatment group (n = 18)

Pre-treatment

Post-treatment

Pre-treatment

Post-treatment

BW (kg)

5.4 (5.40-6.15)

5.4 (5.00-6.15)

5.45 (3.47-6.98)

5.32 (3.60-5.73)

BSC

5.4 (5.40-6.15)

5.4 (5.00-6.15)

6.3 (5.40-7.20)

6.3 (5.55-7.20)

HR (beats/min)

95 ± 18

87 ± 6

118 ± 31

134 ± 15

SBP (mmHg)

155 ± 28

152 ± 36

155 ± 28

155 ± 33

DBP (mmHg)

91 ± 10

95 ± 18

88 ± 15

93 ± 19

MAP (mmHg)

127 ± 23

111 ± 19

110 ± 18

117 ± 19

  1. The values of BW and BCS are presented as median (interquartile range). The values of HR, PR, SBP, DBP, and MAP are presented as mean ± SD. BCS body condition score, BW body weight, HR heart rate, PR pulse rate, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial blood pressure